Vilo Research Group Inc., founded in 2016 by Dr. Jorge Mendez and Karem Obmaces, is a clinical research network that conducts Phase I to IV clinical research studies. Over the years, the company has been committed to providing sponsors with accurate data to support the development of new drugs and assist healthcare professionals.
The company aims to improve minority health and reduce ethnic and geographic disparities in metabolic, cardiovascular, and related conditions.
Specific details about the philosophical underpinnings of the company are that it operates with a commitment to ethical research conduct, scientific rigor, and patient-centered care, as is common in the clinical research industry. The philosophy likely aligns with the overarching principles of advancing medical knowledge with integrity and compassion.